A carregar...
Peginterferon beta-1a was associated with high adherence and satisfaction in patients with multiple sclerosis in a German real-world study
BACKGROUND: Peginterferon beta-1a was developed for treatment of relapsing–remitting multiple sclerosis (RRMS) to provide an interferon with increased exposure to facilitate adherence by reducing frequency of application. This non-interventional observational study investigated the adherence to pegi...
Na minha lista:
| Publicado no: | Ther Adv Neurol Disord |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7983429/ https://ncbi.nlm.nih.gov/pubmed/33796146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17562864211000461 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|